Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Although oral metronomic chemotherapy is often used in progressive pediatric solid malignant tumors, a literature review reveals that only small single-arm retrospective or phase 1 and 2 studies have been performed. Skepticism abounds because of the lack of level 1 evidence.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): JAMA Oncol

Title: JAMA oncology

Publisher: American Medical Association (AMA)

ISSN (Electronic): 2374-2445

ISSN (Print): 2374-2437

Publication date (Electronic): Sep 01 2017

Volume: 3

Issue: 9

Affiliations

[1 ] Department of Medical Oncology, All India Institute of Medical Sciences, New Delhi, India.

[2 ] Department of Pediatric Surgery, All India Institute of Medical Sciences, New Delhi, India.

[3 ] Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, India.

[4 ] Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, India.

[5 ] Department of Biostatistics, All India Institute of Medical Sciences, New Delhi, India.

Article

Publisher Item ID: 2616355

DOI: 10.1001/jamaoncol.2017.0324

PMC ID: 5824286

PubMed ID: 28384657

SO-VID: d19a4d54-5fd3-41cf-a75d-1c809401902c

History

Data availability:

Metronomic Chemotherapy vs Best Supportive Care in Progressive Pediatric Solid Malignant Tumors: A Randomized Clinical Trial.

Read this article at

Abstract

Related collections

Pediatric Pulse: Advancing Neonatal and Child Health

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 20